Sponsor: Spiro Medical, Inc. · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 30 pts
Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.
Download $49 NCT07709754 Rescue Dossier →